Don Miller, Senior Content Manager at MarketBeat

Articles Reviewed by Don Miller - Page 55

December 29, 2023 7:32 AM ET

Microsoft is new cybersecurity titan, challenging big tech rivals

Kate Stalter

Microsoft is a key player in cybersecurity, competing with companies such as CrowdStrike and Amazon. Its annual cybersecurity business grew to $20 billion.

NASDAQ:MSFTNASDAQ:GOOGLNASDAQ:AMZN

December 29, 2023 6:45 AM ET

Cruise lines navigate from worst to first in 2023 surge

Kate Stalter

The cruise industry has transformed itself, led by Royal Caribbean, Carnival and Norwegian. Companies focus on affordable pricing and higher profit margins.

NYSE:CCLNYSEARCA:XLYNYSE:NCLH

December 29, 2023 6:41 AM ET

Small-cap surge: Outpacing large caps on hopes for '24 rate cuts

Kate Stalter

Small-cap stocks surged past large caps recently, fueled by lower interest rates and renewed economic confidence. Small growth and value are both rallying.

NYSE:MTHNASDAQ:SPSCNYSEARCA:SPY

December 29, 2023 6:40 AM ET

Synopsys stock: Unsung hero of the AI revolution

Kate Stalter

Synopsis, the leading provider of electronic design automation software, is up more than 60% in 2023 as customers AMD, Nvidia and Intel expand AI capabilities.

NASDAQ:SNPSNASDAQ:ALTRNASDAQ:ANSS

December 29, 2023 6:28 AM ET

Apple stock is institutional favorite, but is it overvalued?

Kate Stalter

Despite a strong performance in 2023, the company's revenue and earnings growth are slowing. Should investors keep holding, or is the stock overvalued?

NASDAQ:AAPLNASDAQ:GOOGLNASDAQ:AMZN

December 28, 2023 8:35 AM ET

Insiders bet big on these turnaround stocks

Thomas Hughes

Insiders are buying Bally's, Delcath Systems and Perrigo while their shares are at historic lows and catalysts are ahead.

NASDAQ:DCTHNYSE:BALYNYSE:PRGO

December 28, 2023 7:45 AM ET

Rivian is all set to start 2024 with a bang

Sam Quirke

Rivian shares are up 53% since the middle of November, more than twice that of Tesla's 21% return and almost four times that of the DRIV ETF's 14% return.

NASDAQ:AMZNNASDAQ:TSLANASDAQ:RIVN

December 28, 2023 7:38 AM ET

If you buy the dogs, should you sell these Dow leaders?

Thomas Hughes

The Dogs of the Dow is a great strategy for value and income, but letting the winners run is equally essential to maximize returns.

NYSE:CRMNASDAQ:INTCNASDAQ:MSFT

December 28, 2023 6:52 AM ET

Ray Dalio keeps adding to this ETF, what's he thinking?

Gabriel Osorio-Mazilli

Ray Dalio is going to be happy with his newest purchases into Asian stocks, there are two in particular that could bring in a good bulk of returns to this play

OTCMKTS:SSNLFOTCMKTS:TCEHYNASDAQ:PDD

December 28, 2023 6:45 AM ET

2 Tech stocks getting bullish upgrades ahead of Q1

Sam Quirke

Stocks the analysts are upgrading tend to outperform their peers. With that in mind, here are two tech stocks that analysts have just upgraded ahead of 2024.

NYSE:CRMNASDAQ:FROG

December 28, 2023 5:00 AM ET

What to expect from the Q1 earnings reporting cycle

Thomas Hughes

The FQ4 earnings reporting season starts soon and will determine the S&P 500's direction in 2024. The risk is that gains will be capped but there is hope.

NYSEARCA:XLUNYSEARCA:XLKNYSEARCA:XLC

December 27, 2023 12:19 PM ET

SoftBank's billion-dollar bet pays off

Jeffrey Neal Johnson

SoftBank achieves a substantial financial boost from a telecom merger presenting a mixed risk-reward scenario for potential investors.

OTCMKTS:SFTBYNASDAQ:TMUSNYSE:WE

December 27, 2023 9:42 AM ET

Are high-yield Dow Dogs a good buy for 2024?

Thomas Hughes

These Dow Dogs are also the highest-yielding names on the Dow list. All are trading near recent bottoms and pay above-average yields with an average above 6%.

NYSE:VZNYSE:MMMNASDAQ:WBA

December 27, 2023 9:23 AM ET

Synopsys offers to acquire Ansys, sparks stock surge

Kate Stalter

Ansys stock rose 18% on Synopsys acquisition news. Fellow engineering software maker Altair also rose on speculation it may be an acquisition target.

NASDAQ:ANSSNASDAQ:ALTRNASDAQ:ADSK

December 27, 2023 8:35 AM ET

The most upgraded stocks from 2023: buy, sell or hold?

Thomas Hughes

The most upgraded stocks in 2023 had solid years with at least a 55% upside; most increased more than 100%, and another year of gains is forecast for 2024.

NYSEARCA:SPYNASDAQ:MSFTNASDAQ:NVDA

December 27, 2023 8:35 AM ET

Buffett keeps buying Occidental Petroleum, should you?

Thomas Hughes

Berkshire Hathaway buys more OXY and sends the shares moving up from the bottom of a range; higher prices are ahead and may be reached soon.

NYSE:OXY

December 27, 2023 7:04 AM ET

The truth behind NIO's 60.0% upside

Gabriel Osorio-Mazilli

NIO stock is on the rise, and its most recent quarter points to some of the reasons why traders are buying record volumes of call options, going up?

NYSE:GSNYSE:NIOOTCMKTS:BYDDY

December 27, 2023 6:57 AM ET

Liquidia: Court victory the awakening of an industry giant?

Ryan Hasson

Liquidia's stock surged after an enormous court win against United Therapeutics, accompanied by analyst upgrades and insider buying.

NASDAQ:UTHRNASDAQ:LQDA

December 27, 2023 6:55 AM ET

T-Mobile is suddenly the industry gem with analyst target boosts

Gabriel Osorio-Mazilli

T-Mobile is delivering everything investors would hope for, upside and safety, growth projections above competitors, and even a price target boost!

NYSE:WFCNYSE:UBSNYSE:UBER

December 27, 2023 5:30 AM ET

Could Cleveland-Cliffs be the next steel company to be acquired?

Jea Yu

On Dec. 18, 2023, Iconic steel producer United States Steel Inc. announced it had agreed to be acquired by Japan’s largest steel maker, Cleveland-Cliffs next ?

NYSE:CLFOTCMKTS:NPSCYNYSE:NUE

December 27, 2023 5:12 AM ET

Markets love XPO, your stuff still needs to get where it's going

Gabriel Osorio-Mazilli

The transport industry keeps adding jobs, and a 2024 filled with potential rate cuts can spur further activity into these stocks, but only one can be a winner

NYSE:XPONASDAQ:JBHTNASDAQ:SAIA

December 27, 2023 5:00 AM ET

CRISPR Therapeutics sets sights on gene-editing cures for disease

Jea Yu

On Dec. 8, 2023, Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) announced the U.S. FDA approved its sickle-cell disease (SCD) treatment, Casgevy, for

NASDAQ:CRSPNASDAQ:VRTXNASDAQ:NTLA

December 26, 2023 6:59 AM ET

Affirm Holdings: Time to ring the register?

Jea Yu

Buy-now-pay-later (BNPL) platform provider Affirm Holdings Inc. (NASDAQ: AFRM) stock is up 439% year-to-date (YTD). If you’re wondering if

NASDAQ:AFRMNYSE:SHOPNYSE:SQ

December 26, 2023 6:19 AM ET

Carvana: cash out or hold tight?

Ryan Hasson

CVNA has skyrocketed 1,054% this year on surprising earnings and huge short interest, and Its RSI of 67.28 suggests that it's not yet in overbought territory.

NYSE:CVNA

Page 55 of 67

« Most Recent ‹ More Recent 52 53 54 55 56 57 58 Earlier › Earliest »

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Don Miller, Senior Content Manager at MarketBeat

Articles Reviewed by Don Miller - Page 55

Microsoft is new cybersecurity titan, challenging big tech rivals

Cruise lines navigate from worst to first in 2023 surge

Small-cap surge: Outpacing large caps on hopes for '24 rate cuts

Synopsys stock: Unsung hero of the AI revolution

Apple stock is institutional favorite, but is it overvalued?

Insiders bet big on these turnaround stocks

Rivian is all set to start 2024 with a bang

If you buy the dogs, should you sell these Dow leaders?

Ray Dalio keeps adding to this ETF, what's he thinking?

2 Tech stocks getting bullish upgrades ahead of Q1